75D301-25-R-73207 Amendment 0001.pdf
PDF 659 KB Posted
- Solicitation number
- 75D301-25-R-73207
About this file
This document is an amendment to a federal solicitation for Diagnostic Test Development and Production for Emergency Response. The purpose of this amendment is to provide answers to vendor questions, extend the solicitation due date, and revise applicable dates within the solicitation.
The key details are:
- This is a new contracting action without an incumbent vendor or current contract.
- The solicitation is for the development, validation, and production of Nucleic Acid Amplification Tests for selected pathogens, with the option to submit tests for regulatory approval and manufacture the approved tests.
- The Period of Performance is from the date of award through 4 years and 364 days after award.
- Pricing is Firm Fixed Price, with a Not-to-Exceed value for certain line items.
- The initial response due date has been extended from 12/2/2024 to 12/13/2024, and the deadline for submitting questions has been extended from 11/18/2024 to 11/29/2024.
- The contracting office is the Centers for Disease Control and Prevention Office of Acquisition Services.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 75D301-25-R-73207 Amendment 0002.pdf | ||
| Pricing Table (Protected).xlsx | XLSX spreadsheet | |
| 75D301-25-R-73207 Combined Synopsis and Solicitation Final.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:
(a) By completing items 8 and 15, and returning or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
E. IMPORTANT: Contractor is not is required to sign this document and return copies to the issuing office.
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE
2. AMENDMENT/MODIFICATION NUMBER 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQUISITION NUMBER 5. PROJECT NUMBER (If applicable)
7. ADMINISTERED BY (If other than Item 6) CODE
STANDARD FORM 30 (REV. 11/2016)
Prescribed by GSA FAR (48 CFR) 53.243
FACILITY CODE
9A. AMENDMENT OF SOLICITATION NUMBER
9B. DATED (SEE ITEM 11)
10A. MODIFICATION OF CONTRACT/ORDER NUMBER
10B. DATED (SEE ITEM 13)
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended. is not extended.
12. ACCOUNTING AND APPROPRIATION DATA (If required) copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;
13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.
IT MODIFIES THE CONTRACT/ORDER NUMBER AS DESCRIBED IN ITEM 14.
CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER
NUMBER IN ITEM 10A.
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
D. OTHER (Specify type of modification and authority)
Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
15C. DATE SIGNED
15A. NAME AND TITLE OF SIGNER (Type or print)
16C. DATE SIGNED
16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)
14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
PAGE OF PAGES
6. ISSUED BY CODE
8. NAME AND ADDRESS OF CONTRACTOR (Number, street, county, State and ZIP Code) (X)
CODE
15B. CONTRACTOR/OFFEROR
(Signature of person authorized to sign)
16B. UNITED STATES OF AMERICA
(Signature of Contracting Officer)
Previous edition unusable
The purpose of this amendment is to provide answers to questions submitted by prospective vendors, extend the solicitation due date, and revise applicable dates within the solicitation.
Point of Contacst: Contract Specialists Austin Pagliaccetti, email: zsm6@cdc.gov and Shayna Connery, email xvj9@cdc.gov.
Both should be included on all correspondence.
(See Continuation Pages)
Centers for Disease Control and Prevention Chamblee Campus Building 102, MS S102-4 4770 Buford Hwy Atlanta, GA 30341-3717 Atlanta, GA 30341-4004
000HCAD1-2024-84620
75D301-25-R-73207
1 6
11/14/2024
11/7/2024
75D301-25-R-73207
Diagnostic Test Development and Production for Emergency Response Solicitation
SECTION SF 30 BLOCK 14 CONTINUATION PAGE
SUMMARY OF CHANGES
The following have been added by full text:
QUESTIONS AND RESPONSES
1. QUESTION: Is there a current vendor performing services that are listed within the Sam notice or is this the first iteration of these services? Please provide current contract number and vendor.
RESPONSE: This is a new action without an incumbent vendor or contract currently in place.
(End of Questions and Responses)
SOLICITATION 75D301-25-R-73207 ISSUED NOVEMBER 7, 2024
1. STANDARD FORM (SF) 1449 BLOCK EIGHT (8) CONTINUATION:
The following SF 1449 continuation information has been changed from:
Response DUE Date/time: 12/2/2024/Before 12:00 pm Eastern Time
Questions DUE Date/time: 11/18/2024/Before 12:00 pm Eastern Time
To:
Response DUE Date/time: 12/13/2024/Before 12:00 pm Eastern Time
Questions DUE Date/time: 11/29/2024/Before 12:00 pm Eastern Time
2. SECTION B – CONTINUATION OF SF 1449
SCHEDULE OF SUPPLIES/SERVICES
The following items have changed in Schedule of Supplies/Services Table from:
ITEM 0001 Period of Performance (POP)/Ordering Period: February 7, 2025 – February 6, 2026
And
ITEMs 0002, 000201, 000202, 000203, 0003, 0004, 000401, 000402, 0005 POP/Ordering Period: February 7, 2025 – February 6, 2030
Diagnostic Test Development and Production for Emergency Response Solicitation
To:
ITEM SUPPLIES / SERVICES QTY / UNIT UNIT PRICE Maximum Contract Value
0001 Diagnostic Development and Validation Plan
Firm Fixed Price (FFP) Non-Severable
Period of Performance (POP)/ Ordering Period:
To Be Determined (TBD) 2025 Date of Award – 364 Days After Award (2026)
Minimum Value see B.3
$10,000.00
NTE
$10,000.00 NTE
0002 Test development, validation, and production.
This is a FFP Line Item Severability to be determined at Task Order (TO) level.
POP/Ordering Period:
TBD 2025 Date of Award – Four (4) Years, 364 Days After Award (2030)
Maximum Value see B.3
000201 Test development and validation from a CDC Laboratory Developed Test, with clinical validation specimens available from CDC.
Validation includes generation of a data package sufficient for submission to FDA for EUA or 510(k), but not actual submission.
This is a FFP Line Item Severability to be determined at TO level.
POP/Ordering Period:
TBD 2025 Date of Award – Four (4) Years, 364 Days After Award (2030)
000202 Test development and validation for a pathogen with no existing LDT, with sequence data and pathogen samples available from CDC, in advance of an outbreak. Validation includes generation of a data package sufficient for submission to FDA for EUA or 510(k), but not actual submission.
This is a FFP Line Item Severability to be determined TO level.
POP/Ordering Period:
TBD 2025 Date of Award – Four (4) Years, 364 Days After Award (2030)
Diagnostic Test Development and Production for Emergency Response Solicitation
000203 Test development and validation for a pathogen with no existing LDT, with sequence data and pathogen samples available from CDC, in response to an outbreak (expedited timeframe required). Validation includes generation of a data package sufficient for submission to FDA for EUA or 510(k), but not actual submission.
This is a FFP Line Item Severability to be determined TO level.
POP/ Ordering Period:
0003 Test submission for regulatory approval for a selected pathogen
This is a FFP Line Item Severability to be determined TO level.
POP/ Ordering Period:
TBD 2025 Date of Award – Four (4) Years, 364 Days After Award (2030)
Maximum Value see B.3
0004 Manufacturing of test for the selected pathogen
This is a FFP Line Item Severability to be determined TO level.
POP/ Ordering Period:
TBD 2025 Date of Award – Four (4) Years, 364 Days After Award (2030)
Maximum Value see B.3
000401 Test manufacturing per test in lots of 100,000- 999,999
This is a FFP Line Item Severability to be determined TO level.
POP/ Ordering Period:
000402 Test manufacturing per test in lots of greater than 1,000,000
This is a FFP Line Item Severability to be determined TO level.
POP/ Ordering Period:
Diagnostic Test Development and Production for Emergency Response Solicitation
0005 Travel
This is a Severable, Cost-Reimbursable line item.
For planning purposes, this item will be executed only if applicable to IDIQ Task Order.
POP/ Ordering Period:
TBD 2025 Date of Award – Four (4) Years, 364 Days After Award (2030)
$20,000.00
NTE
$20,000.0
0 NTE
3. SECTION C – CONTRACT CLAUSES
The following instruction to offerors has been changed from:
52.216-18 Ordering. (AUG 2020)
(a) Any supplies and services to be furnished under this contract shall be ordered by issuance of delivery orders or task orders by the individuals or activities designated in the Schedule. Such orders may be issued from January 27, 2025 through January 26, 2030.
To:
52.216-18 Ordering. (AUG 2020)
(a) Any supplies and services to be furnished under this contract shall be ordered by issuance of delivery orders or task orders by the individuals or activities designated in the Schedule. Such orders may be issued from TBD 2025 Date of Award – Four (4) Years, 364 Days After Award (2030).
(b) All delivery orders or task orders are subject to the terms and conditions of this contract. In the event of conflict between a delivery order or task order and this contract, the contract shall control.
(c) A delivery order or task order is considered “issued” when-
(1) If sent by mail (includes transmittal by U.S. mail or private delivery service), the
Government deposits the order in the mail;
(2) If sent by fax, the Government transmits the order to the Contractor’s fax number; or
(3) If sent electronically, the Government either-
(i) Posts a copy of the delivery order or task order to a Government document access system, and notice is sent to the Contractor; or
(ii) Distributes the delivery order or task order via email to the Contractor’s email address.
(d) Orders may be issued by methods other than those enumerated in this clause only if authorized in the contract.
(End of clause)
Diagnostic Test Development and Production for Emergency Response Solicitation
4. SECTION E – SOLICITATION PROVISIONS
The following instruction to offerors has been changed from:
CDCA_L002 Inquiries (Jul 2017) Inquiries concerning the solicitation document should be submitted in writing to the issuing office. Any additions, deletions, or changes to the solicitation will be made by an amendment.
OFFERORS ARE INSTRUCTED SPECIFICALLY TO CONTACT ONLY THE
SOLICITATION CONTRACTING OFFICE IN CONNECTION WITH ANY ASPECT OF
THIS REQUIREMENT PRIOR TO CONTRACT AWARD. PROPOSALS AND ALL
CORRESPONDENCE RELATING TO THE SOLICITATION DOCUMENT SHALL BE
SUBMITTED TO THE CONTRACTING OFFICE.
Inquiries should be received by the Contracting Office no later November 18, 2024 12:00 pm Eastern Time and may be submitted via e-mail to xvj9@cdc.gov and zsm6@cdc.gov.
To:
Inquiries should be received by the Contracting Office no later November 29, 2024 12:00 pm Eastern Time and may be submitted via e-mail to xvj9@cdc.gov and zsm6@cdc.gov.
(End of Summary of Changes) mailto:xvj9@cdc.gov mailto:zsm6@cdc.gov mailto:xvj9@cdc.gov mailto:zsm6@cdc.gov
| _SF30-16c (2).pdf |
| Solicitation 75D301-25-R-73207 - Amendment 0001.pdf |
| SECTION SF 30 BLOCK 14 CONTINUATION PAGES.pdf |
File details come from the government source that posted it. Updated .